Colgate-Palmolive Company (CL) closed at $95.29 on October 30, 2026, up 2.3% from the previous close, on volume of 7,836,386 shares (30-day average 4,980,962).
Data as of October 30, 2026.
New CEO at Clorox brings strong turnaround experience—Evercore ISI
Seeking Alpha News (Mon, 2-Nov 11:53 AM ET)
Colgate-Palmolive (CL) Receives a Buy from RBC Capital
TipRanks (Mon, 2-Nov 10:28 AM ET)
Wells Fargo Reaffirms Their Hold Rating on Colgate-Palmolive (CL)
TipRanks (Sun, 1-Nov 8:35 PM ET)
Colgate-Palmolive Earnings Call Highlights Resilient Growth
TipRanks (Sat, 31-Oct 8:11 PM ET)
Seeking Alpha News (Sat, 31-Oct 10:10 AM ET)
Options Volatility and Implied Earnings Moves Today, October 30, 2026
TipRanks (Fri, 30-Oct 8:05 AM ET)
Colgate-Palmolive gains after Q3 sales beat, higher earnings forecast
Seeking Alpha News (Fri, 30-Oct 7:38 AM ET)
Colgate-Palmolive posts 60.2% gross margin in Q3 as it raises full-year profit outlook
Market Chameleon (Fri, 30-Oct 3:38 AM ET)
Colgate-Palmolive Non-GAAP EPS of $0.97 beats by $0.04, revenue of $5.37B beats by $40M
Seeking Alpha News (Fri, 30-Oct 6:56 AM ET)
Colgate-Palmolive Announces 3rd Quarter 2026 Results
Business Wire (Fri, 30-Oct 6:55 AM ET)
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns the specialty pet food maker Hill's (which accounts for almost one-fourth of its sales), where the majority of its products are sold through veterinarians and specialty pet retailers.
Colgate-Palmolive Company trades on the NYSE stock market under the symbol CL.
As of November 2, 2026, CL stock price climbed to $97.56 with 2,999,905 million shares trading.
CL has a beta of 0.14, meaning it tends to be less sensitive to market movements. CL has a correlation of 0.01 to the broad based SPY ETF.
CL has a market cap of $77.55 billion. This is considered a Large Cap stock.
Last quarter Colgate-Palmolive Company reported $5 billion in Revenue and $.97 earnings per share. This beat revenue expectation by $36 million and exceeded earnings estimates by $.05.
In the last 3 years, CL traded as high as $109.30 and as low as $73.97.
The top ETF exchange traded funds that CL belongs to (by Net Assets): VTI, VOO, IVV, SPY, VO.
CL has outperformed the market in the last year with a price return of +30.3% while the SPY ETF gained +11.9%. CL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +7.1% and +4.2%, respectively, while the SPY returned +1.8% and -1.4%, respectively.
CL support price is $93.76 and resistance is $96.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CL shares will trade within this expected range on the day.
